Course Complete
59 results
1 - 59
Course Complete
Miscellaneous
Course Feedback
Indications for Preoperative Neoadjuvant Therapy
Fundamentals of Rectal Cancer Surgery
Colorectal Cancer: Management of Distant Metastases
Colorectal Cancer: Postoperative Adjuvant Therapy and Surveillance
Rectal Cancer: Neoadjuvant Therapy
Anal Intraepithelial Neoplasia
Benign Disease- A 35-year-old patient with a BMI of 33 presents after his third episode of diverticulitis in the past 6 years is referred to your clinic for follow-up from a recent diverticulitis flare. He completed a 10-day course of augmentin and is currently nontender. Computed tomography (CT) of the abdomen and pelvis completed 2 weeks ago is shown. Colonoscopy from 1 year ago demonstrated diverticulosis in the sigmoid colon. This third attack marks the second time he has had to cancel a business trip because of his diverticulitis. The best recommendation for him at this point is
- A 55-year-old man with a history of ulcerative colitis (UC) diagnosed in his early 20s presents with a new diagnosis of distal rectal moderately differentiated adenocarcinoma. Mismatch repair (MMR) protein expression is intact; routine surveillance endoscopy showed a mass starting ~2 cm from the anal verge with all other biopsies negative for dysplasia. Laboratory results reveal unremarkable levels of carcinoembryonic antigen (CEA), comprehensive metabolic panel (CMP), and complete blood count (CBC). Systemic staging is negative for metastatic disease. Local staging with magnetic resonance imaging (MRI) reveals a T3N1 lesion. Based on a multidisciplinary tumor board discussion, the patient is planned for total neoadjuvant chemotherapy with upfront chemoradiation followed by consolidation chemotherapy. After this therapy is completed, what is the optimal surgical course for this patient?
Malignancy
Rectal Cancer: Nonoperative Management
Male Genitourinary Dysfunction as a Consequence of Colorectal Surgery
General Postoperative Complications
Malignancy- A healthy 65-year-old male patient is diagnosed with a moderately differentiated rectal adenocarcinoma, microsatellite stable. Staging was negative for metastatic disease. Pelvic magnetic resonance imaging (MRI) shows possible involvement of the prostate with mesorectal lymph nodes suspicious for metastasis. What is the current recommended course of treatment for this patient, given these findings?
- A 57-year-old man undergoes total neoadjuvant therapy (TNT) for management of a cT3N1M0 rectal cancer. After completion of both chemotherapy/radiotherapy and consolidation chemotherapy, the presence of complete clinical response to treatment is assessed by
Rationale for Multimodality Therapy
Proctectomy for Rectal Cancer
Anal Cancer
Rectal Prolapse
Large Bowel Obstruction
Surgical Techniques for Length
Management of Rectal Cancer 2023 Supplement (2023)
Surgical Management of Ulcerative Colitis (2021)
Anorectal Disease
Local Excision
Colon and Rectal Surgery Educational Program (CARSEP)
Treatment of Chronic Radiation Proctitis (2018)
Rectal Cancer Biology and Hereditary Cancer Syndromes
Minimally Invasive Complete Mesocolic Excision with Extended Lymphadenectomy for Colon Cancer
Management of Rectal Cancer (2020)
Dermatology and Pruritus Ani
Rectal Cancer Pathology Assessment
Gastrointestinal Stromal Tumors, Neuroendocrine Tumors, and Lymphoma
Considerations for Geriatric Patients Undergoing Colorectal Surgery
Rectovaginal Fistula
Anal Squamous Cell Cancers (Revised 2018)
Treatment of Left-Sided Colonic Diverticulitis (2020)
Rectal Prolapse
Surgical Management of Crohn's Disease (2020)
Evaluation and Management of Chronic Constipation (2024)
Colorectal Cancer: Preoperative Evaluation and Staging
Management of Clostridioides difficile Infection (2021)
Welcome to Litigation
Surveillance and Survivorship Care of Patients After Curative Treatment of Colon and Rectal Cancer (2021)
Perioperative Evaluation and Management of Frailty Among Older Adults Undergoing Colorectal Surgery (2022)

